To access this element change to forms mode OFF
Grant Award View - GA8846
The development of industry-independent cancer clinical trial protocols.
GA ID:
GA8846
Agency:
Cancer Australia
Approval Date:
29-Jun-2018
Publish Date:
5-Jul-2018
Category:
Cancer
Grant Term:
1-Jul-2018 to 1-Mar-2022
Original: 1-Jul-2018 to 1-Sep-2021
Value (AUD):
$1,925,000.00
(GST inclusive where applicable)
Original:
$1,650,000.00
Variations:
- GA8846-V1 - To enable the continued development of industry-independent cancer clinical trial protocols (13-Dec-2021 )
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
CA 18/19 Improved cancer control
Grant Program:
Support for Cancer Clinical Trials Program
Grant Activity:
The development of industry-independent cancer clinical trial protocols.
Purpose:
Clinical trials benefit the community by improving the survival of people affected by cancer, and contribute to a reduction in premature death and disability. Clinical trials are fundamental to establishing if new cancer treatments, diagnostic tests or preventive interventions are effective and they help generate evidence for best-practice cancer care.
GO ID:
GO Title:
Support for Cancer Clinical Trials Program
Internal Reference ID:
Support for Cancer Clinical Trials Program
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
Australasian Leukaemia and Lymphoma Group
Recipient ABN:
96 066 593 100
Grant Recipient Location
Suburb:
Richmond
Town/City:
Melbourne
Postcode:
3121
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
National
Postcode:
Multiple
Country:
AUSTRALIA